Scientists from Levon Orbeli Institute of Physiology of NAS RA have received an antidote against gyurza bites. "Once registered, this antidote may enter the domestic and foreign markets. Its effectiveness is not inferior to the drugs of international manufacturers in the market," Naira Ayvazyan, Doctor of Biological Sciences, Head of Scientific Group, Director of the Institute of Physiology after Levon Orbeli of NAS RA said. She noted that research has shown that gyurza venom exhibits unique anti-cancer, anti-neurodegenerative properties.
Most of the scientists involved in the research are young professionals and applicants for PhD. Master's students of Yerevan State University were also involved in the works.
The scientific results were obtained within the framework of the basic topic within the Institute of Physiology after Levon Orbeli of NAS RA.
Scientific articles on the results have been published in prestigious scientific journals, in particular, Journal of Membrane Biology, Journal of Venom Research, Journal of Biotechnology, Molecular Biology, etc.
"We have been contacted by the largest French antidote manufacturer INOSAN, asking them to check the activity of their products against the venom of our endemic snakes. Russian conferences have been the basis for new cooperation," Naira Ayvazyan noted.
Information and Analysis Service of NAS RA
September 16, 2021 at 14:03